Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)

NCT05081557 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05081557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05081557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
November 17, 2021
Completion date
October 31, 2026
Enrollment
873 (actual)
Sites
140

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis